Citi Adjusts Catalyst Watch Names May 13, 2026 04:09PM
Zenas BioPharma prices $300 million dual offering of notes and stock Mar 27, 2026 12:13AM
Zenas BioPharma Announces Pricing of Concurrent Public Offerings of 2.50% Convertible Senior Notes Due 2032 and Common Stock with Aggregate Gross Proceeds of $300.0 Million Mar 27, 2026 12:12AM
Zenas BioPharma launches dual public offerings of notes and stock Mar 26, 2026 04:01PM
Zenas BioPharma Announces Proposed Concurrent Public Offerings of Convertible Senior Notes Due 2032 and Common Stock Mar 26, 2026 04:01PM


Jan 5, 2026 02:19PM Zenas Biopharma (ZBIO) PT Lowered to $43 at Citi
Aug 26, 2025 07:05AM Zenas BioPharma to Present at Upcoming Healthcare Investor Conferences
Jul 10, 2025 05:48AM Citi Reiterates Buy Rating on Zenas Biopharma (ZBIO)
Nov 7, 2024 07:05AM Zenas BioPharma to Participate in Upcoming Healthcare Investor Conferences
Oct 8, 2024 04:01AM Citi Starts Zenas Biopharma (ZBIO) at Buy
Sep 19, 2024 04:15PM Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering
Sep 13, 2024 06:18AM Zenas BioPharma (ZBIO) Prices Upsized 13.24M Share IPO at $17/sh
Sep 12, 2024 10:37PM Zenas BioPharma Announces Pricing of Upsized Initial Public Offering